Pliant Therapeutics, Inc. · NASDAQ:PLRX
Morgan Stanley reported a 6.10% stake in Pliant Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 6, 2025
Morgan Stanley reported a 6.10% stake in Pliant Therapeutics, Inc., 3,737,335 shares, as a passive investor on Jun 30, 2025. Filed Aug 6, 2025 (Schedule 13G).
- Stake
- 6.10%
- Shares
- 3,737,335
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 6.10% | 3,737,335 |
Source
Related
- Pliant Therapeutics, Inc.
- Morgan Stanley
- Pliant Therapeutics, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Jan 8, 2026
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 17, 2026
- Schedule 13G · Citadel Advisors LLC · Feb 9, 2026